Thbs4 Secreted Factor Induces Beige Adipocyte Transformation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively address metabolic disorders caused by high-fat diets, particularly in improving systemic glucose and lipid metabolism.

Innovation Solution

The use of a recombinant skeletal muscle secreted factor Thbs4 protein or an expression vector that induces the expression of genes related to mitochondrial metabolism and thermogenesis, activating a beige-like change in white adipose tissue to increase metabolic rate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to address metabolic disorders, then treatment options are limited, but effectiveness in improving systemic glucose and lipid metabolism is insufficient

Engineering Contradiction:
Improveeffectiveness in improving systemic glucose and lipid metabolismVSAvoidtreatment options for metabolic disorders
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent introduces Thbs4 as an intermediary substance that mediates the interaction between skeletal muscle and white adipose tissue. Thbs4 secreted by skeletal muscle acts on white adipose tissue to induce beige-like changes, thereby improving metabolic disorders. This intermediary mechanism provides a novel therapeutic approach that bridges muscle function and metabolic regulation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent utilizes parameter changes in the biological system by modifying the expression level of Thbs4 protein. By increasing Thbs4 expression through recombinant protein administration or gene therapy, the patent achieves transformation of white adipose tissue phenotype, thereby improving glucose and lipid metabolism parameters.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If exercise is used to induce skeletal muscle secreted factors, then metabolic benefits are achieved, but the complexity and duration of intervention increase

Engineering Contradiction:
Improvemetabolic benefitsVSAvoidintervention duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The patent applies preliminary action by directly administering Thbs4 recombinant protein or Thbs4-expressing vectors to achieve the metabolic benefits of exercise without requiring actual exercise intervention. This preliminary introduction of the key secreted factor bypasses the need for prolonged exercise training while still achieving the desired metabolic effects.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent extracts the key active component (Thbs4) from the complex exercise-induced physiological response. By isolating and administering this specific secreted factor, the patent separates the beneficial metabolic effect from the complex and time-consuming exercise intervention, achieving the same outcome through a simplified approach.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Thbs4 increases metabolic rate, alleviates metabolic disorders caused by high-fat diets, and demonstrates potential in treating metabolic disorders by improving glucose and lipid metabolism.

Implementation Method 1

The Thbs4 recombinant protein induces the expression of genes related to mitochondrial metabolism and thermogenesis in C3H10/T2 or primary white adipocytes (SVF) in vitro

Methodology Applied
Scientific EffectThermogenesis:

Data Source

PatentUS11969457B2Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism
Publication Date: 2024.04.30 GUANGDONG INST OF MICROBIOLOGY GUANGDONG DETECTION CENT OF MICROBIOLOGY
  • US11969457B2 patent drawing
  • US11969457B2 patent drawing
  • US11969457B2 patent drawing

AI summary

An application of a skeletal muscle secreted factor Thbs4 in a preparation of a drug for improving systemic glucose and lipid metabolism is provided. According to the present invention, it is found through experiments that Thbs4 increases a body's metabolic rate by activating a beige-like change of white adipose, relieves the metabolic disorder caused by high-fat diet, and reveals its application value in the treatment of the metabolic disorder.